Fapon
↗Dongguan, China
Fapon is a global life sciences company that provides integrated solutions for in vitro diagnostics (IVD), biopharma, and biotherapy. The company is a leading supplier of IVD raw materials (antigens, antibodies, enzymes) and has expanded into developing open-system diagnostic instruments, AI-driven diagnostic platforms, and innovative biopharmaceutical pipelines targeting oncology and autoimmune diseases.
Founded in 2001 and headquartered in Dongguan, China, Fapon operates a global ecosystem that includes R&D centers and offices in various regions, including the United States. The company leverages AI for enzyme engineering and drug discovery, aiming to provide comprehensive, one-stop solutions to diagnostic laboratories and biopharma partners worldwide.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:In Vitro Diagnostics (IVD) & Biopharma
SIZE & FINANCIALS
Employees:1001-5000
Founded:2001
Ownership:private
Status:operating
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical
Modalities:Therapeutic antibodies, Fusion proteins, Circular RNA
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Fapon Biotech, Fapon Biopharma, Fapon Digiwiser, Halo Bio
Key Partnerships:Collaborations with various global IVD manufacturers for raw material supply., Collaboration with Halo Bio (Dr. Alex Wesselhoeft) on circular RNA technology.
COMPETITION
Position:Challenger
Competitors:Roche Diagnostics, Danaher (Beckman Coulter), Thermo Fisher Scientific, Abbott Laboratories
LEADERSHIP
Key Executives:
Buyong Ma - Founder and Chief Scientist of Digiwiser
LINKS
Website:fapon.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Fapon and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Fapon. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.